KATRD
LOGIN
- KATRD 2025 International Conference
-
October 29(Wed)-31(Fri), 2025 Lotte Hotel World, Seoul, Kore
- Program
Program in Detail
- ALL
-
- ALL
- Plenary Session
- ATS-KATRD Joint Symposium
- JRS-KATRD Joint Symposium
- MTS-KATRD Joint Symposium
- Airway
- Bronchoscopy
- Asthma
- COPD
- Cough
- Critical Care Medicine
- Thoracic Ultrasound
- Environmental Lung Disease
- ILD
- Lung Cancer
- Pulmonary Rehabilitation
- Pulmonary Vascular Disease
- Tuberculosis
- Editors Desk
- Infection
- 한국어교육세션
- 일선진료의를 위한 결핵 강좌
- 연구비발표
- Luncheon Symposium
- Satellite Symposium
- Ceremony
- Oral
Panelists are identified by asterisk(*) marks.
Thursday, October 30 |
||
|
Luncheon Symposium 1 COPD  |
Thursday, October 30,
12:00-12:30 Room 1 CRYSTAL 1 (3F) |
|
|---|---|---|
| Chair | Yeon-Mok Oh (University of Ulsan, Korea) | |
| 12:00-12:30 |
Key Findings of Indacaterol/Glycopyrronium in COPD
Wisia Wedzicha (Imperial College London, UK)
|
|
|
Luncheon Symposium 2 ILD  |
Thursday, October 30,
12:00-12:30 Room 2 CRYSTAL 2 (3F) |
|
| Chair | Yangjin Jegal (Seoul National University, Korea) | |
| 12:00-12:30 |
Progress to PerFection: Navigating the Path from Diagnosis to Advanced Treatment of PPF
Martin Kolb (McMaster University, Canada)
|
|
|
Luncheon Symposium 3 Lung Cancer  |
Thursday, October 30,
12:00-12:30 Room 3 CRYSTAL 3 (3F) |
|
| Chair | In-Jae Oh (Chonnam National University, Korea) | |
| 12:00-12:30 |
The LASER Effect : Lazertinib's Rise as a New SoC in EGFR m+ NSCLC 1st Line Treatment
Mi-Hyun Kim (Pusan National University, Korea)
|
|
|
Luncheon Symposium 4 Asthma  |
Thursday, October 30,
12:00-12:30 Room 4 EMERALD (3F) |
|
| Chair | Seong Yong Lim (Sungkyunkwan University, Korea) | |
| 12:00-12:30 |
Making Sense of Severe Asthma Today : Insights from Guidelines and New Evidences
Arnaud Bourdin (University of Montpellier, France)
|
|
Friday, October 31 |
||
|
Luncheon Symposium 5 COPD  |
Friday, October 31,
11:50-12:20 Room 1 CRYSTAL 1 (3F) |
|
| Chair | Seoung Ju Park (Jeonbuk National University, Korea) | |
| 11:50-12:20 |
Disease Stability in COPD: An Important Treatment Goal
Dave Singh (University of Manchester, UK)
|
|
|
Luncheon Symposium 6 ILD  |
Friday, October 31,
11:50-12:20 Room 2 CRYSTAL 2 (3F) |
|
| Chair | Moo Suk Park (Yonsei University, Korea) | |
| 11:50-12:20 |
Innovative Therapeutic Frontiers: The Current and Future Pharmacological Landscape for Idiopathic Pulmonary Fibrosis (IPF)
Kevin Brown (National Jewish Center, USA)
|
|
|
Luncheon Symposium 7 Lung cancer  |
Friday, October 31,
11:50-12:20 Room 3 CRYSTAL 3 (3F) |
|
| Chair | Seung Hun Jang (Hallym University, Korea) | |
| 11:50-12:20 |
When Standard isn’t Enough: A New treatment pathway with FLAURA2
Seong Hoon Yoon (Pusan National University, Korea)
|
|
|
Luncheon Symposium 8 Asthma  |
Friday, October 31,
11:50-12:20 Room 4 EMERALD (3F) |
|
| Chair | Won Yeon Lee (Yonsei University Wonju College of Medicine, Korea) | |
| 11:50-12:20 |
From Guidelines to Practice: The Role of Budesonide/Formoterol in GINA 2025
Hyun Lee (Hanyang University, Korea)
|
|